| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032658031 |
| P356 | DOI | 10.1007/S10544-016-0072-0 |
| P932 | PMC publication ID | 4920071 |
| P698 | PubMed publication ID | 27206512 |
| P50 | author | Ian Papautsky | Q88748662 |
| ??? | Q60185281 | ||
| Himanshu Shekhar | Q42534376 | ||
| P2093 | author name string | George J Shaw | |
| Madhuvanthi A Kandadai | |||
| Prithviraj Mukherjee | |||
| P2860 | cites work | Shaken and stirred: mechanisms of ultrasound-enhanced thrombolysis | Q27303116 |
| Phospholipid-Stabilized Microbubble Foam for Injectable Oxygen Delivery | Q42875576 | ||
| Morphological study of acoustic liposomes using transmission electron microscopy | Q43244185 | ||
| Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents | Q43824779 | ||
| Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing | Q44783153 | ||
| Microbubble size isolation by differential centrifugation. | Q47210345 | ||
| Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: a study of SonoVue. | Q47224012 | ||
| Attenuation and size distribution measurements of Definity and manipulated Definity populations | Q47286860 | ||
| CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke | Q47737677 | ||
| Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials | Q47963971 | ||
| Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator | Q48481255 | ||
| Inadequate acoustical temporal bone window in patients with a transient ischemic attack or minor stroke: role of skull thickness and bone density. | Q51716845 | ||
| Effects of ambient hydrostatic pressure on the material properties of the encapsulation of an ultrasound contrast microbubble. | Q51788288 | ||
| Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis | Q67552832 | ||
| Ultrasound scattering properties of Albunex microspheres | Q70685705 | ||
| Quantification of transpulmonary echocontrast effects | Q72869484 | ||
| Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz | Q73128929 | ||
| Ultrasound reversibly disaggregates fibrin fibers | Q73727696 | ||
| Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidase | Q73916722 | ||
| Enhancement of fibrinolysis with 40-kHz ultrasound | Q77298911 | ||
| Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator | Q81497174 | ||
| Fluid Viscosity Affects the Fragmentation and Inertial Cavitation Threshold of Lipid-Encapsulated Microbubbles | Q30362514 | ||
| Recombinant protein-stabilized monodisperse microbubbles with tunable size using a valve-based microfluidic device | Q30402286 | ||
| Thrombolytic efficacy and enzymatic activity of rt-PA-loaded echogenic liposomes | Q30408623 | ||
| Gauging the likelihood of stable cavitation from ultrasound contrast agents | Q30409299 | ||
| In silico study of low-frequency transcranial ultrasound fields in acute ischemic stroke patients. | Q30410602 | ||
| Enhanced intracellular delivery of a model drug using microbubbles produced by a microfluidic device | Q30412245 | ||
| Liquid Flooded Flow-Focusing Microfluidic Device for in situ Generation of Monodisperse Microbubbles | Q30414617 | ||
| Flow-focusing regimes for accelerated production of monodisperse drug-loadable microbubbles toward clinical-scale applications | Q30422675 | ||
| Modifying the size distribution of microbubble contrast agents for high-frequency subharmonic imaging. | Q30433867 | ||
| Ultrasound-mediated drug delivery for cardiovascular disease. | Q30438336 | ||
| Broadband attenuation measurements of phospholipid-shelled ultrasound contrast agents | Q30438378 | ||
| Experimental validation of a finite-difference model for the prediction of transcranial ultrasound fields based on CT images. | Q30446132 | ||
| Influence of lipid shell physicochemical properties on ultrasound-induced microbubble destruction | Q30446982 | ||
| A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery | Q30448009 | ||
| Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model. | Q30448853 | ||
| Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter | Q30461828 | ||
| Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes | Q30477053 | ||
| Ultrasound-enhanced thrombolysis using Definity as a cavitation nucleation agent. | Q30479478 | ||
| Controllable microfluidic synthesis of multiphase drug-carrying lipospheres for site-targeted therapy | Q30480712 | ||
| Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes | Q30480851 | ||
| Tissue plasminogen activator concentration dependence of 120 kHz ultrasound-enhanced thrombolysis. | Q30485761 | ||
| Tailoring the size distribution of ultrasound contrast agents: possible method for improving sensitivity in molecular imaging | Q30494515 | ||
| On-chip generation of microbubbles as a practical technology for manufacturing contrast agents for ultrasonic imaging | Q30496810 | ||
| Correlation of cavitation with ultrasound enhancement of thrombolysis | Q30502209 | ||
| Long-term stability of recombinant tissue plasminogen activator at -80 C. | Q33476541 | ||
| Introduction to ultrasound contrast agents: physics overview | Q33797546 | ||
| Long-term stability by lipid coating monodisperse microbubbles formed by a flow-focusing device | Q35914697 | ||
| Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. | Q36701086 | ||
| 20 years of ultrasound contrast agent modeling | Q38071528 | ||
| Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke | Q39536240 | ||
| Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity | Q40235883 | ||
| Manufacture of concentrated, lipid-based oxygen microbubble emulsions by high shear homogenization and serial concentration | Q42548896 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microfluidics | Q138845 |
| P304 | page(s) | 48 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | Biomedical Microdevices | Q4915116 |
| P1476 | title | Microfluidic manufacture of rt-PA -loaded echogenic liposomes. | |
| P478 | volume | 18 |
| Q57155947 | Engineering Theranostic Microbubbles Using Microfluidics for Ultrasound Imaging and Therapy: A Review |
| Q91754378 | In vitro characterization of sonothrombolysis and echocontrast agents to treat ischemic stroke |
| Q51070200 | In vitro thrombolytic efficacy of echogenic liposomes loaded with tissue plasminogen activator and octafluoropropane gas. |
| Q49853329 | Liposomes for the delivery of streptokinase |
| Q46942228 | Loss of gas from echogenic liposomes exposed to pulsed ultrasound |
| Q90226164 | Targeted Delivery of Plasminogen Activators for Thrombolytic Therapy: An Integrative Evaluation |
| Q47931181 | Tissue plasminogen activator-based nanothrombolysis for ischemic stroke |
Search more.